Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias
Cells · 13.02.2023 · 12 (4) · 601
DOI: 10.3390/cells12040601 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 13.02.2023. Verfasst von Alexandra F Putka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Human studies, in combination with animal and cellular models, support glial cells as both major contributors to neurodegenerative diseases and promising therapeutic targets. Among glial cells, oligodendrocytes and Schwann cells are the myelinating glial cells of the central and peripheral nervous system, respectively. In this review, we discuss the contributions of these central and peripheral myelinating glia to the pathomechanisms of polyglutamine (polyQ) spinocerebellar ataxia (SCA) types 1, 2, 3, 6, 7, and 17. First, we highlight the function of oligodendrocytes in healthy conditions and how they are disrupted in polyQ SCA patients and diseased model systems. We then cover the role of Schwann cells in peripheral nerve function and repair as well as their possible role in peripheral neuropathy in polyQ SCAs. Finally, we discuss potential polyQ SCA therapeutic interventions in myelinating glial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA.
ORCID-Profile: Alexandra F Putka, Juan P Mato, Hayley S McLoughlin
Förderung
- NINDS NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Putka, A. F., Mato, J. P., & McLoughlin, H. S. (2023). Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias. Cells, 12(4), 601. https://doi.org/10.3390/cells12040601
Vancouver
Putka AF, Mato JP, McLoughlin HS. Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias. Cells. 2023;12(4):601. doi:10.3390/cells12040601
BibTeX
@article{Putka2023,
author = {Putka, Alexandra F and Mato, Juan P and McLoughlin, Hayley S},
title = {Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias},
journal = {Cells},
year = {2023},
volume = {12},
number = {4},
pages = {601},
doi = {10.3390/cells12040601}
}
EUVIMED